Lavipharm (ATH:LAVI) Days Payable : 177.05 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Days Payable?

Lavipharm's average Accounts Payable for the six months ended in Dec. 2023 was €10.19 Mil. Lavipharm's Cost of Goods Sold for the six months ended in Dec. 2023 was €10.51 Mil. Hence, Lavipharm's Days Payable for the six months ended in Dec. 2023 was 177.05.

The historical rank and industry rank for Lavipharm's Days Payable or its related term are showing as below:

ATH:LAVI' s Days Payable Range Over the Past 10 Years
Min: 83.36 Med: 91.92 Max: 123.5
Current: 123.5

During the past 7 years, Lavipharm's highest Days Payable was 123.50. The lowest was 83.36. And the median was 91.92.

ATH:LAVI's Days Payable is ranked better than
66.94% of 971 companies
in the Drug Manufacturers industry
Industry Median: 88.69 vs ATH:LAVI: 123.50

Lavipharm's Days Payable increased from Dec. 2022 (159.71) to Dec. 2023 (177.05). It may suggest that Lavipharm delayed paying its suppliers.

Lavipharm Days Payable Historical Data

The historical data trend for Lavipharm's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Days Payable Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

108.18

89.97

83.36

120.26

116.61

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial					91.78	101.21	159.71	96.39	177.05

Competitive Comparison of Lavipharm's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's Days Payable distribution charts can be found below:

* The bar in red indicates where Lavipharm's Days Payable falls into.

Lavipharm Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Lavipharm's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (7.766	+	9.955)	/	2 )	/	27.733	*	365
=	8.8605					/	27.733	*	365
=	116.61

Lavipharm's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (10.431	+	9.955)	/	2 )	/	10.507	*	365 / 2
=	10.193					/	10.507	*	365 / 2
=	177.05

Lavipharm Days Payable Related Terms

Thank you for viewing the detailed overview of Lavipharm's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm (ATH:LAVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm (ATH:LAVI) Headlines

No Headlines